Skin tissue is highly responsive to hormonal signaling, particularly changes in estrogen levels during perimenopause and menopause. While collagen loss and visible skin aging are often associated with getting older, research continues to show that estrogen plays an important role in maintaining dermal integrity, hydration, elasticity, and overall tissue health.1
For healthcare providers, skin-related concerns may offer valuable insight into broader endocrine changes occurring during hormonal transition. Many clinicians now recognize that symptoms such as thinning skin, delayed wound healing, dryness, and loss of elasticity may reflect shifts in collagen metabolism and reduced estrogen activity rather than age alone.
Pellecome®, founded by board-certified OB-GYN Dr. Enrique G. Jacome, was developed to help providers deliver personalized Bio-Identical Hormone Replacement Therapy (BHRT) solutions through streamlined pellet therapy protocols. With decades of experience and more than 30,000 pellet implants placed, Dr. Jacome’s evidence-informed approach supports healthcare professionals managing patients affected by hormone-related physiologic changes.
Estrogen’s Role in Collagen and Skin Integrity
Estrogen contributes significantly to skin structure through its influence on collagen synthesis and dermal function. Estrogen receptors are widely distributed throughout skin tissue, allowing hormonal signaling to directly affect fibroblast activity, hydration, wound healing, and extracellular matrix maintenance.1
Collagen types I and III are responsible for maintaining skin strength, elasticity, and thickness. Research suggests estrogen also supports:
- Hyaluronic acid production and skin hydration
- Epidermal barrier function
- Tissue repair and wound healing
- Protection against oxidative stress within skin tissue1,2
As estrogen production decreases, these protective mechanisms gradually weaken. Studies suggest women may lose a substantial amount of collagen during the first several years after menopause, contributing to noticeable structural skin changes.1
How Hormonal Changes Affect Skin Structure
Reduced estrogen activity may contribute to several clinically observable changes involving skin quality and tissue resilience, including:
- Dermal thinning
- Increased skin fragility
- Dryness and irritation
- Reduced elasticity
- Fine lines and wrinkling
- Delayed wound healing
- Increased bruising tendency2
Hormonal changes may also impair epidermal barrier performance and moisture retention. Research examining postmenopausal skin has demonstrated lower hydration levels and increased transepidermal water loss compared to premenopausal skin tissue.2
These findings often occur alongside other systemic symptoms associated with hormonal transition, including fatigue, vasomotor symptoms, sleep disruption, mood changes, and body composition shifts. Emerging research also continues to reinforce the importance of individualized timing and hormone assessment when addressing menopause-related physiologic changes and long-term tissue health.3
For providers, recognizing skin changes as part of a broader endocrine picture may help support earlier evaluation and more comprehensive treatment planning.
Why Skin Changes May Warrant Hormone Evaluation
Although many patients initially seek care for cosmetic concerns, visible skin changes may indicate underlying hormonal imbalance or physiologic transition. A comprehensive assessment that includes symptom history, lifestyle factors, and hormone evaluation may help providers better understand the broader factors influencing tissue health and patient well-being.
Individualized hormone optimization strategies may help support collagen maintenance, epidermal integrity, and overall skin function while also addressing systemic symptoms associated with estrogen deficiency.
Pellecome® supports providers with evidence-informed BHRT solutions designed to promote consistent hormone delivery and individualized patient care. Through ongoing provider education and streamlined pellet therapy systems, Pellecome continues to help healthcare professionals navigate the evolving landscape of hormone optimization and women’s health.
Supporting Providers With Evidence-Informed BHRT Solutions
Founded by board-certified OB-GYN Dr. Enrique G. Jacome, Pellecome® remains committed to equipping healthcare professionals with evidence-informed Bio-Identical Hormone Replacement Therapy (BHRT) solutions and high-quality products designed to support individualized patient care.
As research continues to expand our understanding of estrogen’s role in collagen production, skin integrity, and connective tissue health, providers are increasingly recognizing the relationship between visible skin changes and broader endocrine function. A more comprehensive understanding of hormone-related physiologic changes may help clinicians better support long-term tissue health, wellness, and quality of life throughout hormonal transition.
To learn more about Pellecome® and provider partnership opportunities, contact Pellecome® today.
- Amini N, Osterlund C, Curpen J, Lafon-Kolb V, Richard T, Visdal-Johnsen L. Phytoestrogens as natural anti-aging solutions for enhanced collagen synthesis in skin. J Cosmet Dermatol [Internet]. 2025;24(2):e16719. Available from: http://dx.doi.org/10.1111/jocd.16719
- Caring for your skin in menopause [Internet]. Aad.org. [cited 2026 May 27]. Available from: https://www.aad.org/public/everyday-care/skin-care-secrets/anti-aging/skin-care-during-menopause
- Nikoletić ĐC, Ivanov D, Levakov O, Bulajić J, Lukač S, Rakić VK, et al. Menopause, menstrual cycle, and skin barrier function. Skin Res Technol [Internet]. 2025;31(7):e70203. Available from: http://dx.doi.org/10.1111/srt.70203
